Description of Medical ServiceCharacterisation of VHL, TP53, RB1 status, TFE3 / Xp11.1 translocation and detection of chromosome 3 (chr3) monosomy for the diagnosis of RCC; characterisation of ploidy status for the diagnosis and classification of patients with hydatidiform moles; classification of mutation in FOXL2 (402C>G) for the diagnosis of granulosa cell ovarian tumour; detection of somatic gene rearrangements for the diagnosis of salivary gland tumours including mammary analogue secretory carcinoma, hyalinising clear cell carcinoma, mucoepidermoid and NUT midline carcinomas; and characterisation of somatic tumour gene rearrangements for the diagnosis of secretory carcinoma of the breast.
Description of Medical ConditionRenal cell carcinoma (RCC); hydatidiform moles; granulosa cell ovarian tumour; salivary gland tumours; and secretory carcinoma of the breast.
Reason for ApplicationNew MBS item
Medical Service TypeInvestigative
Previous Application NumberNot Applicable
Application FormApplication Form (Word 191 KB)
Application Form (PDF 1060 KB)
Consultation SurveyConsultation Survey (Word 508 KB)
Consultation Survey (PDF 304 KB)
Public Summary DocumentPublic Summary Document (Word 81 KB)
Public Summary Document (PDF 377 KB)
Meetings for this Application
PASC12-13 April 2018
MSAC1-2 August 2019
28-29 November 2019